Healthcare Services

Vascular Dementia Market Revenue Projected to Reach $5.62 Billion by 2030 at 11.4% CAGR

April 28, 2026April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Vascular Dementia Market In 2026 And 2030?

The vascular dementia market size has experienced significant expansion in recent years. It is forecast to grow from $3.27 billion in 2025 to $3.65 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.8%. The expansion observed in prior periods can be attributed to a rising incidence of stroke-related cognitive decline, increasing prevalence of hypertension and diabetes, the growth of neurological research programs, enhanced diagnostic awareness, and the development of hospital-based dementia care.

The vascular dementia market size is anticipated to undergo swift expansion in the forthcoming years. It is forecast to grow to $5.63 billion in 2030, registering a compound annual growth rate (CAGR) of 11.4%. The projected growth during this period stems from an increasing aging population, rising investments in neurological drug development, the growing adoption of digital health monitoring tools, the expansion of precision medicine approaches, and a heightened focus on long-term cognitive health management. Key trends observed in the forecast period encompass an increasing emphasis on the early diagnosis of cognitive disorders, the rising integration of digital cognitive assessment tools, expanding research into vascular-related neurodegeneration, the broadening of personalized treatment approaches, and an enhanced focus on preventive care strategies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20998&type=smp

Which Primary Drivers Are Impacting The Vascular Dementia Market Growth?

The growing occurrence of cardiovascular disease is anticipated to boost the vascular dementia market in the future. Cardiovascular diseases encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and hypertension. This increase in cardiovascular diseases is fueled by elements like unhealthy lifestyles, inadequate diets, lack of physical activity, elevated stress, an aging global populace, and a rise in risk factors including obesity, diabetes, and hypertension. By hindering blood flow to the brain, cardiovascular disease heightens the risk of vascular dementia, resulting in cognitive impairment and damage to brain cells because of insufficient oxygen and nutrient delivery. For example, data released in September 2024 by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that in the UK, roughly 7.6 million individuals suffer from heart and circulatory diseases, comprising about 4 million males and 3.6 million females. These illnesses contribute to approximately 27% of all fatalities in the UK, amounting to over 170,000 deaths each year, or roughly 480 deaths daily, which means one death occurs every three minutes. Consequently, the growing incidence of cardiovascular diseases is a key driver for the vascular dementia market.

What Are The Different Segment Types In The Vascular Dementia Market Segment Breakdown?

The vascular dementia market covered in this report is segmented –

1) By Product: Small Molecules / Drugs, Lifestyle And Nutraceutical Interventions, Rehabilitation Therapies

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By End User: Hospitals And Clinics, Rehabilitation Centers, Specialty Clinics

Subsegments:

1) By Small Molecules Or Drugs: Antihypertensives, Anti-diabetic agents, Lipid-lowering agents, Anti-inflammatory agents, Neuroprotective small molecules

2) By Lifestyle And Nutraceutical Interventions: Vitamins & Supplements, Omega-3 Or DHA formulations, Antioxidants

3) By Rehabilitation Therapies: Cognitive enhancers, Physical therapy programs, Occupational therapy aids

Which Trends Are Shaping Growth In The Vascular Dementia Market?

Leading companies within the vascular dementia market are concentrating on creating innovative treatments, particularly multimodal therapies, to uphold their competitive standing. Multimodal therapies entail the integration of diverse treatment strategies, such as pharmaceutical interventions, physical rehabilitation, and psychological support, to address a condition comprehensively. For example, in January 2023, Moleac, a Singaporean biopharmaceutical firm, introduced CognivAiD, an evidence-based therapy specifically formulated for vascular dementia (VaD), a condition currently lacking extensive therapeutic options. This product merges active extracts from ginkgo, ginseng, and saffron, which have demonstrated a notable ability to slow cognitive decline in VaD patients. CognivAiD’s unique multimodal action specifically targets crucial mechanisms of vascular dementia, including vascular protection, vasoregulation, and neuroinflammation. Supported by comprehensive clinical trials and a strong safety profile, CognivAiD represents a promising new treatment avenue for individuals affected by VaD.

Who Are The Well-Known Companies In The Vascular Dementia Market?

Major companies operating in the vascular dementia market are Charsire Biotechnology Corp, ProNeurogen Therapeutics, Resverlogix Corp, Cyclerion Therapeutics Inc, CSPC-NBP Pharma, Johnson & Johnson Services Inc, Materia Medica Holding, Eisai Co Ltd, Shineway Pharmaceutical, Merz Pharma, Ever Neuro Pharma GmbH, Zhejiang Otsuka Pharma, Pfizer Inc, Biogen Inc, Novartis AG, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd, Teva Pharmaceuticals, Zydus Cadila, Eli Lilly and Company

Get The Full Vascular Dementia Market Report:

https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report

Which Region Represents The Largest Share Of The Vascular Dementia Market?

North America was the largest region in the vascular dementia market in 2025. The regions covered in the vascular dementia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Vascular Dementia Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report

Browse Through More Reports Similar to the Global Vascular Dementia Market 2026, By The Business Research Company

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Vascular Imaging Market Report

https://www.thebusinessresearchcompany.com/report/vascular-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795